BrainBridge, a pioneering neuroscience and biomedical engineering startup, has announced plans to develop a revolutionary head transplant system. The company aims to conduct the first procedure within the next decade, as outlined on its website.
Key to this innovative process is sourcing brain-dead donors while ensuring the recipient retains memories, cognitive abilities, and consciousness. This breakthrough holds promise for individuals grappling with conditions such as paralysis, specific cancers, Alzheimer’s, and Parkinson’s disease.
Renowned Yemeni molecular biologist and science communicator Hashem Al-Ghaili took to Instagram on May 21 to herald the advent of BrainBridge, hailing it as the world’s inaugural concept for a head transplant system. Al-Ghaili expounded on the technology’s fusion of advanced robotics and artificial intelligence, envisioning a future where complete head and face transplantation procedures are executed seamlessly.
Al-Ghaili expressed optimism that this groundbreaking technology could offer a lifeline to individuals afflicted with otherwise untreatable conditions.
BrainBridge intends to leverage high-speed robotic systems to forestall brain cell degradation and facilitate the seamless integration of a transplanted head with a donor body. Cutting-edge molecular imaging and advanced AI will ensure precision in reconnecting the spinal cord, nerves, and blood vessels.
Central to BrainBridge’s approach is its integrated robotics platform featuring two autonomous surgical robots capable of conducting simultaneous surgeries on two bodies within a single setup. The company plans to employ a proprietary chemical adhesive, polyethylene glycol, to aid in reconnecting severed neurons.
Additionally, a specialized spinal implant will foster neuron repair and facilitate the formation of new neural connections between the patient’s brain and the new body. Patients will also receive a BrainBridge Headband equipped with Brain-Computer Interface (BCI) technology, enabling them to communicate their needs during the recovery phase.
